Gabriele E. Ackermann

1 ta ish

Novartis (Switzerland)

1. Introduction of Sacubitril/Valsartan in Primary Care Follow-Up of Heart Failure: A Prospective Observational Study (THESEUS)

   Thomas Dieterle, Stefan Schaefer, Ina Meyer +3

   MaqolaOAOchiq kirish20200 iqtibos

   ABIABI:AkademIndex/2020.article.006674